Skip to content
Home/Companies/Biotech/Immunocore
IM

Immunocore

Biotech·UK·Active·5yr hold

Immunocore is a healthcare company, headquartered in United Kingdom.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Immunocore?

Immunocore is currently owned by Rosetta Capital through Rosetta Capital V (2021 vintage), since 2021. Across its history, Immunocore has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Rosetta Capital
Most recent investor
Rosetta Capital
Rosetta Capital V · 2021 · Secondaries
2 ownership periods · full history below

Key facts

HQUnited Kingdom
SectorHealthcare

Ownership history

2 ownership periods

Active
Co-held by Rosetta Capital and General Atlantic since 2021.
Rosetta Capital
Rosetta CapitalActive
2021 · present · Rosetta Capital V · 2021 · Secondaries
MOIC
–
General Atlantic
General AtlanticActive
present · General Atlantic Portfolio · Buyout
MOIC
–

More from Rosetta Capital V

Other portfolio companies in the same fund.

Carrick Therapeutics
Active
BiotechIreland· 2021
Inivata
Active
HealthTechUK· 2021
Mereo BioPharma
Active
BiotechUK· 2021
Mission Therapeutics
Active
BiotechUK· 2021
PsiOxus Therapeutics
Active
BiotechUK· 2021
ReNeuron
Active
BiotechUK· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings